NYSE:MED - Medifast Stock Price, Price Target & More

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Medifast announced a quarterly dividend on Friday, March 16th. Stockholders of record on Friday, March 30th will be paid a dividend of $0.48 per share on Tuesday, May 8th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date of this dividend is Wednesday, March 28th. View Medifast's Dividend History.

Medifast Inc (NYSE:MED) issued its quarterly earnings data on Thursday, May, 3rd. The specialty retailer reported $1.01 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.86 by $0.15. The specialty retailer earned $98.60 million during the quarter, compared to analyst estimates of $89.23 million. Medifast had a return on equity of 31.11% and a net margin of 10.26%. The business's quarterly revenue was up 39.7% on a year-over-year basis. During the same period last year, the firm posted $0.36 EPS. View Medifast's Earnings History.

Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Medifast.

Medifast updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $3.55-3.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.24. The company issued revenue guidance of $385-395 million, compared to the consensus revenue estimate of $354.90 million.Medifast also updated its Q2 guidance to $0.94-0.97 EPS.

2 Wall Street analysts have issued 1-year price objectives for Medifast's stock. Their forecasts range from $55.00 to $161.00. On average, they expect Medifast's share price to reach $108.00 in the next year. View Analyst Ratings for Medifast.

Some companies that are related to Medifast include McCormick & Company (MKC), Want Want China (WWNTY), Greencore (GNCGY), Farmer Brothers (FARM), China Marine Food Group (CMFO) and Jammin Java (JAMN).

Media coverage about MED stock has been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Medifast earned a media sentiment score of 0.11 on Accern's scale. They also assigned media stories about the specialty retailer an impact score of 45.04 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Medifast's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.40%), Millennium Management LLC (2.40%), American Century Companies Inc. (1.82%), Summit Trail Advisors LLC (1.45%), Northern Trust Corp (1.12%) and Old Mutual Global Investors UK Ltd. (1.09%). Company insiders that own Medifast stock include Balanced Master Fund L Visium, Charles P Connolly, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.

MED stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., American Century Companies Inc., HL Financial Services LLC, BNP Paribas Arbitrage SA, Seizert Capital Partners LLC, JPMorgan Chase & Co., Wells Fargo & Company MN and GSA Capital Partners LLP. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Glenn W Welling, Jeremy John Martin, Michael C Macdonald and Ralph Rushton. View Insider Buying and Selling for Medifast.

MED stock was purchased by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Millennium Management LLC, Prudential Financial Inc., Great Lakes Advisors LLC, Allianz Asset Management GmbH, Allianz Asset Management GmbH, Landscape Capital Management L.L.C. and Old Mutual Global Investors UK Ltd.. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MED stock can currently be purchased for approximately $140.58.

Medifast has a market capitalization of $1.70 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe.

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]